EP1311516A1 - Novel amidite derivatives for synthesising polymers on surfaces - Google Patents
Novel amidite derivatives for synthesising polymers on surfacesInfo
- Publication number
- EP1311516A1 EP1311516A1 EP01969645A EP01969645A EP1311516A1 EP 1311516 A1 EP1311516 A1 EP 1311516A1 EP 01969645 A EP01969645 A EP 01969645A EP 01969645 A EP01969645 A EP 01969645A EP 1311516 A1 EP1311516 A1 EP 1311516A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- compound according
- compound
- linker
- split
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 24
- 239000007787 solid Substances 0.000 claims abstract description 12
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 11
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 11
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 7
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 5
- 125000006239 protecting group Chemical group 0.000 claims description 36
- 150000001875 compounds Chemical class 0.000 claims description 30
- 238000003786 synthesis reaction Methods 0.000 claims description 21
- 230000015572 biosynthetic process Effects 0.000 claims description 20
- 125000005647 linker group Chemical group 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 238000010532 solid phase synthesis reaction Methods 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229930195733 hydrocarbon Natural products 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 229920001222 biopolymer Polymers 0.000 abstract description 9
- 230000001066 destructive effect Effects 0.000 abstract description 4
- 239000000969 carrier Substances 0.000 abstract description 2
- 125000006850 spacer group Chemical group 0.000 description 13
- 239000000523 sample Substances 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- -1 cyanoethoxy Chemical group 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000005289 controlled pore glass Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 239000006090 Foturan Substances 0.000 description 1
- 101100144701 Mus musculus Drosha gene Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000007068 beta-elimination reaction Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 108010002712 deoxyribonuclease II Proteins 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/141—Esters of phosphorous acids
- C07F9/1411—Esters of phosphorous acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2408—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
Definitions
- the invention relates to new amidite derivatives and their use as linker building blocks for the synthesis of polymers, in particular biopolymers such as nucleic acids, peptides and saccharides, on the surface of solid supports.
- linker derivatives according to the invention permits non-destructive regeneration of the surfaces.
- biopolymer arrays in which a large number of different biopolymers, such as nucleic acids or peptides, are immobilized on a carrier in defined areas.
- a spacer In the synthesis of biopolymers on a solid phase, a spacer, a so-called spacer, is generally used between the support and the actual biopolymer.
- the use of a spacer has the advantage that the biopolymer is further away from the surface of the solid support, so that its influences are suppressed, so that the immobilized biopolymer can undergo quasi-homogeneous reactions.
- the nature of the spacer, its length, polarity and its other physicochemical properties consequently have a decisive influence on the coupling yield in the polymer system on the support, and thus on the quality of the polymer and its later use.
- R ' represents a protected linker group
- R represents the predecessor synthetic building block or the functional group of a solid phase
- Q represents H or an organic protective group such as cyanoethoxy or methoxy, which plays no role in anchoring on the surface.
- R 1 and R 2 each independently represent a C r C 10 hydrocarbon radical, for example a C r C 6 alkyl radical or the C 3 -C 4 cycloalkyl radical, or are linked to one another, for example to form a 5- or 6-membered ring surrender and
- R 3 and R 4 are each independently a protected linker group of the general formula (II):
- L is a linker
- X is a protecting group
- n is an integer from 1-3.
- R 1 and R 2 are preferably each methyl, ethyl or i-propyl radicals or together they form a morpholine radical.
- R 1 and R 2 are preferably each methyl, ethyl or i-propyl radicals or together they form a morpholine radical.
- other alkyl or cycloalkyl radicals can of course also be used.
- the linker group (II) generally contains linear or branched aliphatic, olefinic and / or aromatic hydrocarbon groups which are optionally substituted by heteroatoms. It preferably contains an alkylene chain in which one or more CH 2 groups can optionally be replaced by heteroatoms such as O, S or NH.
- the chain length of the linker is preferably 1 to 100 atoms, preferably 10 to 45 atoms and particularly preferably 1 to 25 atoms.
- the chain can also contain one or more branches, a linker group preferably up to can contain three branches. The branches can be introduced into the linker group, for example by ⁇ -bis- or tfishydroxy compounds such as tris (hydroxymethyl) aminomethane.
- Suitable protective groups can be selected from nucleic acids or peptides.
- X is preferably a protective group which can be cleaved from the linker by chemical or enzymatic reactions, with the cleavage resulting in a reactive group e.g. a hydroxyl or amino group is released.
- suitable protective groups are acid-labile protective groups such as dimethoxytrityl (DMT), MMT, Pixyl,
- Fpmp base-labile protective groups, such as benzyl, benzoyl, isobutyryl,
- Protecting groups photolabile protecting groups such as NVOC, NPPOC, catalytic, e.g. Pd removable protecting groups such as allyl, AOC and fluoride removable protecting groups such as TMS and derivatives thereof e.g. TBDMS.
- the compounds according to the invention are outstandingly suitable as spacers or spacer units for the synthesis of polymers on solid supports.
- One or more molecules of the compounds (I) can be used for the synthesis of a polymer molecule.
- the compounds (I) are usually first coupled to the support to build up the spacer and then the polymer is synthesized on the spacer using suitable synthesis components.
- Inorganic or organic carriers come into consideration as solid phases, for example functionalized controlled-pore glass (CPG), other glasses such as Foturan, Pyrex or ordinary soda-lime. Glasses, metallic supports such as silicon, or organic resins such as tentagel.
- the carrier is particularly preferably a chip which is used for the synthesis of polymer arrays.
- the present invention thus also relates to a support for solid phase synthesis of the general formula (Ia)
- T is a solid support as previously indicated and R 3 and R 4 are as previously defined.
- the carrier (Ia) is produced by coupling a compound (I) to a reactive group of the carrier, for example a hydroxyl group, with elimination of the - NR 1 NR 2 group. Possibly.
- the support (Ia) can be oxidized with molecular l 2 , the P atom being transferred from oxidation level III to oxidation level V.
- At least one of the protective groups X can be split off at the linkers R 3 and R 4 .
- One or more polymers can be synthesized onto the reactive groups released after the protective groups X have been split off, these polymers being able to be selected from, for example, nucleic acids such as DNA or RNA, nucleic acid analogs such as PNA or LNA, peptides and saccharides.
- the compounds (I) according to the invention are notable for the fact that they do not require a P (V) protective group and, after deblocking and, if appropriate, oxidation to give the phosphate, do not have a negative charge.
- the compounds according to the invention can be used in conjunction with other synthetic building blocks, for example trifunctional sugar or nucleotide units which are provided with orthogonal protective groups, for the construction of polymers and for the non-destructive recycling of the surfaces, without disruptive charges occurring in subsequent syntheses.
- the protective group X is then split, the protective group
- X is orthogonal to a protecting group Y on the polymer synthesis building block.
- X and Y are protective groups orthogonal to one another, where X is, for example, an acid- and / or photolabile protective group and Y is a protective group which can be split off by catalysis and R represents a nucleobase or a fluorophore, a chromophore or another labeling group.
- R represents a nucleobase or a fluorophore, a chromophore or another labeling group.
- RNA section After hybridization, the protective group of the RNA section is split off, resulting in a free 2'-OH group.
- the ribose sugar can then be cleaved in a subsequent chemical reaction step using periodate or other oxidizing agents and the probe can be removed from the reaction carrier by ⁇ -elimination.
- the compound la according to the invention can also be used by means of suitable biochemical approaches without the coupling in of a special molecule for the non-destructive recycling of the surfaces.
- the polymer or oligomer probes linked to the reaction carrier are cleaved with a DNA or RNA-degrading enzyme or a peptide-cleaving enzyme, which leads to partial or complete degradation of the probes.
- the reaction support can then be used again for the synthesis of new probes.
- Suitable enzymes are nucleases such as exonucleases or endonucleases, which attack a strand of nucleic acid from the ends or within the probe strand and leave nucleotides or nucleosides as cleavage products.
- nucleases such as exonucleases or endonucleases
- RNAsen such as RNAse H etc.
- RNAsen selectively cut the RNA part when an RNA-DNA double strand is formed, as a result of which the entire probe is used as the predetermined breaking point in the case of RNA probes and in the case of RNA sections RNA section is cleaved.
- the regeneration of a reaction carrier with DNA probes can also be achieved by using DNAse (DNAse I, DNAse II, etc.), whereby both single-stranded and double-stranded DNA can be degraded.
- DNAse DNAse I, DNAse II, etc.
- Peptide-cleaving enzymes can also be used as a predetermined breaking point for the degradation of peptide probes or peptide sequence sections.
- Another advantage of the compounds according to the invention is that signal amplification takes place due to the branching, since the doping density of the functional groups on the surface is increased. Furthermore, the compounds according to the invention are distinguished by the fact that they enable more cost-effective polymer synthesis and can be easily integrated into the DNA solid-phase synthesis, while at the same time reducing the required amidite ports compared to the use of commercially available amidites.
- the compounds according to the invention are prepared by reacting the mono-protected basic spacer molecules with phosphorus trichloride to give the bisubstituted monochloro derivative.
- the secondary amine is then introduced into the molecule.
- the invention is further illustrated by the following example.
- Fig. 1A The synthesis scheme is shown in Fig. 1A.
- PCI 3 can also be reacted with heterocyclic nitrogen bases, such as pyrrole, triazole or imidazole, and then only with monotritylated triethylene glycol, if appropriate in the presence of an activator, such as tetrazole.
- heterocyclic nitrogen bases such as pyrrole, triazole or imidazole
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Neue Amiditderivate zur Synthese von Polymeren auf OberflächenNew amidite derivatives for the synthesis of polymers on surfaces
Beschreibungdescription
Die Erfindung betrifft neue Amiditderivate und deren Verwendung als Linkerbausteine zur Synthese von Polymeren, insbesondere Biopolymeren wie Nukleinsäuren, Peptiden und Sacchariden, auf der Oberfläche von festen Trägern. Die Verwendung der erfindungsgemäßen Linkerderivate erlaubt eine zerstörungsfreie Regeneration der Oberflächen.The invention relates to new amidite derivatives and their use as linker building blocks for the synthesis of polymers, in particular biopolymers such as nucleic acids, peptides and saccharides, on the surface of solid supports. The use of the linker derivatives according to the invention permits non-destructive regeneration of the surfaces.
Seit Einführung der Synthese von Biopolymeren an festen Oberflächen durch Merryfield im Jahr 1 965 ist eine Vielzahl an Publikationen über diese Technik erschienen. Eine neuere Entwicklung auf diesem Gebiet ist die Herstellung von so genannten Biopolymer-Arrays, bei denen eine Vielzahl unterschiedlicher Biopolymere wie etwa Nukleinsäuren oder Peptide in definierten Flächenbereichen auf einem Träger immobilisiert sind.Since Merryfield introduced the synthesis of biopolymers on solid surfaces in 1 965, a large number of publications on this technique have appeared. A recent development in this area is the production of so-called biopolymer arrays, in which a large number of different biopolymers, such as nucleic acids or peptides, are immobilized on a carrier in defined areas.
Bei der Synthese von Biopolymeren an einer Festphase wird im Allgemeinen ein Abstandhalter, ein so genannter Spacer zwischen dem Träger und dem eigentlichen Biopolymer verwendet. Die Verwendung eines Spacers hat den Vorteil, dass das Biopolymer weiter von der Oberfläche des festen Trägers entfernt ist, so dass dessen Einflüsse zurückgedrängt werden, so dass das immobilisierte Biopolymer quasi homogene Reaktionen eingehen kann. Die Natur des Spacers, sein Länge, Polarität und seine anderen physikochemischen Eigenschaften, haben demzufolge einen entscheidenden Einfluss auf die Kopplungsausbeute bei der Polymersysthese auf dem Träger, damit auf die Qualität des Polymers und auf dessen spätere Anwendung.In the synthesis of biopolymers on a solid phase, a spacer, a so-called spacer, is generally used between the support and the actual biopolymer. The use of a spacer has the advantage that the biopolymer is further away from the surface of the solid support, so that its influences are suppressed, so that the immobilized biopolymer can undergo quasi-homogeneous reactions. The nature of the spacer, its length, polarity and its other physicochemical properties consequently have a decisive influence on the coupling yield in the polymer system on the support, and thus on the quality of the polymer and its later use.
Für den Spaceraufbau werden im Allgemeinen Strategien verwendet, die auf der Polykondensation von im weitesten Sinne Aminosäuremonomeren oder Cyanoethyl- oder anderweitig geschützten Phosphoramiditen bzw. H- Phosphonaten beruhen. Dabei werden üblicherweise Verbindungen mit der folgenden allgemeinen Struktur verwendet:In general, strategies based on the polycondensation of amino acid monomers in the broadest sense are used for the spacer construction or cyanoethyl- or otherwise protected phosphoramidites or H-phosphonates. Compounds with the following general structure are usually used:
R'R '
OO
O QO Q
OO
RR
worin R' eine geschützte Linkergruppe darstellt, R den Vorgänger- Synthesebaustein oder die funktionelle Gruppe einer festen Phase darstellt und Q H oder eine organische Schutzgruppe wie Cyanoethoxy oder Methoxy darstellt, die bei der Verankerung auf der Oberfläche keine Rolle spielt.wherein R 'represents a protected linker group, R represents the predecessor synthetic building block or the functional group of a solid phase and Q represents H or an organic protective group such as cyanoethoxy or methoxy, which plays no role in anchoring on the surface.
Ein wesentlicher Nachteil der bisher bekannten Spacermoleküle sind die negativen Ladungen, die im Rahmen der Abspaltung der Schutzgruppen an den Phosphatgruppen auftreten. Diese zusätzlichen potentiellen Kopplungszentren verhindern ein mögliches Recycling durch geeignete chemische oder enzymatische Vorgehensweisen der Spacer.A major disadvantage of the spacer molecules known hitherto are the negative charges which occur on the phosphate groups as the protective groups are split off. These additional potential coupling centers prevent possible recycling by suitable chemical or enzymatic procedures of the spacers.
Die der Erfindung zu Grunde liegende Aufgabe bestand somit darin, neue Spacerbausteine für die Synthese von Polymeren auf festen Trägern bereitzustellen. Gelöst wird diese Aufgabe durch eine Verbindung der allgemeinen Formel (I) R3 O O RA The object on which the invention is based was therefore to provide new spacer units for the synthesis of polymers on solid supports. This object is achieved by a compound of the general formula (I) R 3 OOR A
.N.N
R1 R2 R 1 R 2
worin R1 und R2 jeweils unabhängig einen CrC10-Kohlenwasserstoffrest, z.B. einen CrC6-Alkylrest der C3-C4-Cycloalkylrest, darstellen oder miteinander verbunden sind, z.B. um einen 5- oder 6-gliedrigen Ring zu ergeben undwherein R 1 and R 2 each independently represent a C r C 10 hydrocarbon radical, for example a C r C 6 alkyl radical or the C 3 -C 4 cycloalkyl radical, or are linked to one another, for example to form a 5- or 6-membered ring surrender and
R3 und R4 jeweils unabhängig eine geschützte Linkergruppe der allgemeinen Formel (II) sind:R 3 and R 4 are each independently a protected linker group of the general formula (II):
L-(X>nL- (X> n
worin L einen Linker, X eine Schutzgruppe und n eine ganze Zahl von 1 - 3 darstellt.where L is a linker, X is a protecting group and n is an integer from 1-3.
in den Verbindungen (I) sind R1 und R2 vorzugsweise jeweils Methyl-, Ethyl -oder i-Propylreste oder sie bilden zusammen einen Morpholinrest. Es können jedoch selbstverständlich auch andere Alkyl- oder Cycloalkylreste verwendet werden.in the compounds (I) R 1 and R 2 are preferably each methyl, ethyl or i-propyl radicals or together they form a morpholine radical. However, other alkyl or cycloalkyl radicals can of course also be used.
Die Linkergruppe (II) enthält im Allgemeinen lineare oder verzweigte aliphatische, olefinische oder/und aromatische Kohlenwasserstoffgruppen, die ggf. durch Heteroatome substituiert sind. Sie enthält vorzugsweise eine Alkylenkette, in der ggf. ein oder mehrere CH2-Gruppen durch Heteroatome wie O, S oder NH ersetzt sein können. Die Kettenlänge des Linkers beträgt vorzugsweise 1 - 1 00 Atome, vorzugsweise 10 - 45 Atome und besonders bevorzugt 1 0 - 25 Atome. Die Kette kann weiterhin eine oder mehrere Verzweigungen enthalten, wobei eine Linkergruppe vorzugsweise bis zu drei Verzweigungen enthalten kann. Die Verzweigungen können in die Linkergruppe beispielsweise durch ω-Bis- oder Tfishydroxyverbindungen wie etwa Tris-(hydroxymethyl)-aminomethan eingeführt werden. In einer besonders bevorzugten Ausführungsform enthält die Linkergruppe (II) eine Struktur, ausgewählt aus (a) (CH2)n-X, worin n = 1 -1 2, vorzugsweise 3 - 6, oder (b) [(CH2)rO]s-X worin r = 1 -4, vorzugsweise 2-3 und s = 1 -1 00, vorzugsweise 3 - 9 beträgt.The linker group (II) generally contains linear or branched aliphatic, olefinic and / or aromatic hydrocarbon groups which are optionally substituted by heteroatoms. It preferably contains an alkylene chain in which one or more CH 2 groups can optionally be replaced by heteroatoms such as O, S or NH. The chain length of the linker is preferably 1 to 100 atoms, preferably 10 to 45 atoms and particularly preferably 1 to 25 atoms. The chain can also contain one or more branches, a linker group preferably up to can contain three branches. The branches can be introduced into the linker group, for example by ω-bis- or tfishydroxy compounds such as tris (hydroxymethyl) aminomethane. In a particularly preferred embodiment, the linker group (II) contains a structure selected from (a) (CH 2 ) n -X, where n = 1 -1 2, preferably 3-6, or (b) [(CH 2 ) r O] s -X where r = 1 -4, preferably 2-3 and s = 1 -1 00, preferably 3-9.
Am Ende bzw. an den Enden der Linkergruppe befinden sich eine oder mehrere Schutzgruppen X, die aus für die Festphasensynthese vonAt the end or at the ends of the linker group there are one or more protective groups X which are suitable for the solid-phase synthesis of
Nukleinsäuren bzw. Peptiden bekannten Schutzgruppen ausgewählt werden können. Vorzugsweise ist X eine Schutzgruppe, die durch chemische oder enzymatische Reaktionen vom Linker abgespalten werden kann, wobei durch die Abspaltung eine reaktive Gruppe z.B. eine Hydroxyl- oder Aminogruppe freigesetzt wird. Beispiele für geeignete Schutzgruppen sind säurelabile Schutzgruppen wie etwa Dimethoxytrityl (DMT), MMT, Pixyl,Known protective groups can be selected from nucleic acids or peptides. X is preferably a protective group which can be cleaved from the linker by chemical or enzymatic reactions, with the cleavage resulting in a reactive group e.g. a hydroxyl or amino group is released. Examples of suitable protective groups are acid-labile protective groups such as dimethoxytrityl (DMT), MMT, Pixyl,
Fpmp, basenlabile Schutzgruppen, wie etwa Benzyl, Benzoyl, Isobutyryl,Fpmp, base-labile protective groups, such as benzyl, benzoyl, isobutyryl,
Phenoxyacetyl, Laevulinyl etc., oxidations- oder/und reduktionslabilePhenoxyacetyl, laevulinyl etc., oxidation and / or reduction labile
Schutzgruppen, photolabile Schutzgruppen, wie etwa NVOC, NPPOC, katalytisch, z.B. durch Pd abspaltbare Schutzgruppen, wie etwa Allyl, AOC und durch Fluorid abspaltbare Schutzgruppen, wie etwa TMS und Derivate davon, z.B. TBDMS.Protecting groups, photolabile protecting groups such as NVOC, NPPOC, catalytic, e.g. Pd removable protecting groups such as allyl, AOC and fluoride removable protecting groups such as TMS and derivatives thereof e.g. TBDMS.
Die erfindungsgemäßen Verbindungen sind hervorragend als Spacer oder Spacerbausteine zur Synthese von Polymeren auf festen Trägern geeignet. Für die Synthese eines Polymermoleküls können ein oder mehrere Moleküle der Verbindungen (I) eingesetzt werden. Dabei werden die Verbindungen (I) üblicherweise zuerst zum Aufbau des Spacers an den Träger gekoppelt und anschließend unter Verwendung geeigneter Synthesebausteine das Polymer auf dem Spacer synthetisiert. Als feste Phasen kommen anorganische oder organische Träger in Betracht, z.B. funktionalisiertes Controlled-Pore-Glas (CPG), andere Gläser wie Foturan, Pyrex oder gewöhnliche Kalk-Natron- Gläser, metallische Träger wie etwa Silizium, oder organische Harze wie etwa Tentagel. Besonders bevorzugt ist der Träger ein Chip, der zur Synthese von Polymer-Arrays eingesetzt wird.The compounds according to the invention are outstandingly suitable as spacers or spacer units for the synthesis of polymers on solid supports. One or more molecules of the compounds (I) can be used for the synthesis of a polymer molecule. The compounds (I) are usually first coupled to the support to build up the spacer and then the polymer is synthesized on the spacer using suitable synthesis components. Inorganic or organic carriers come into consideration as solid phases, for example functionalized controlled-pore glass (CPG), other glasses such as Foturan, Pyrex or ordinary soda-lime. Glasses, metallic supports such as silicon, or organic resins such as tentagel. The carrier is particularly preferably a chip which is used for the synthesis of polymer arrays.
Ein Gegenstand der vorliegenden Erfindung ist somit auch ein Träger zur Festphasensynthese der allgemeinen Formel (la)The present invention thus also relates to a support for solid phase synthesis of the general formula (Ia)
worin T ein fester Träger wie zuvor angegeben ist und R3 und R4 wie zuvor definiert sind. Der Träger (la) wird durch Kopplung einer Verbindung (I) an eine reaktive Gruppe des Trägers, z.B. eine Hydroxygruppe, unter Abspaltung der - NR1 NR2 Gruppe hergestellt. Ggf. kann eine Oxidation des Trägers (la) z.B. mit molekularem l2 erfolgen, wobei das P-Atom von der Oxidationsstufe III in die Oxidationsstufe V überführt wird.wherein T is a solid support as previously indicated and R 3 and R 4 are as previously defined. The carrier (Ia) is produced by coupling a compound (I) to a reactive group of the carrier, for example a hydroxyl group, with elimination of the - NR 1 NR 2 group. Possibly. For example, the support (Ia) can be oxidized with molecular l 2 , the P atom being transferred from oxidation level III to oxidation level V.
An den Linkern R3 und R4 kann mindestens eine der Schutzgruppen X abgespalten werden. Auf die nach Abspaltung der Schutzgruppen X freigesetzten reaktiven Gruppen können ein oder mehrere Polymere synthetisiert werden, wobei diese Polymere aus z.B. Nukleinsäuren wie DNA oder RNA, Nukleinsäurenanaloga wie etwa PNA oder LNA, Peptiden und Sacchariden ausgewählt sein können.At least one of the protective groups X can be split off at the linkers R 3 and R 4 . One or more polymers can be synthesized onto the reactive groups released after the protective groups X have been split off, these polymers being able to be selected from, for example, nucleic acids such as DNA or RNA, nucleic acid analogs such as PNA or LNA, peptides and saccharides.
Die erfindungsgemäßen Verbindungen (I) zeichnen sich dadurch aus, dass sie keine P(V)-Schutzgruppe benötigen und nach Deblockierung und ggf. Oxidation zum Phosphat keine negative Ladung tragen. Auf diese Weise können die erfindungsgemäßen Verbindungen im Zusammenspiel mit anderen Synthesebausteinen, z.B. trifunktionellen Zucker- oder Nukleotideinheiten, die mit orthogonalen Schutzgruppen versehen sind, zum Aufbau von Polymeren und zum zerstörungsfreien Recycling der Oberflächen eingesetzt werden, ohne dass bei nachfolgenden Synthesen störende Ladungen auftreten.The compounds (I) according to the invention are notable for the fact that they do not require a P (V) protective group and, after deblocking and, if appropriate, oxidation to give the phosphate, do not have a negative charge. In this way The compounds according to the invention can be used in conjunction with other synthetic building blocks, for example trifunctional sugar or nucleotide units which are provided with orthogonal protective groups, for the construction of polymers and for the non-destructive recycling of the surfaces, without disruptive charges occurring in subsequent syntheses.
Dabei wird zunächst die erfindungsgemäße Verbindung (I) an eine reaktiveThe compound (I) according to the invention is first reacted
Gruppe, z.B. eine Hydroxygruppe des festen Trägers gekoppelt.Group, e.g. a hydroxyl group of the solid support is coupled.
Anschließend wird die Schutzgruppe X gespalten, wobei die SchutzgruppeThe protective group X is then split, the protective group
X zu einer Schutzgruppe Y auf dem Polymersynthesebaustein orthogonal ist. Nach Beendigung der Polymersynthese und ggf. Deblockierung der resultierenden Polymeren wird die zu den bisher verwendetenX is orthogonal to a protecting group Y on the polymer synthesis building block. After the end of the polymer synthesis and, if necessary, deblocking of the resulting polymers, it becomes the one used previously
Synthesebedingungen orthogonale Schutzgruppe Y abgespalten. EinSynthesis conditions cleaved orthogonal protecting group Y. On
Beispiel für einen derartigen Synthesebaustein mit der allgemeinen Formel ist wie folgt:An example of such a synthesis block with the general formula is as follows:
worin X und Y zueinander orthogonale Schutzgruppen sind, wobei X z.B. eine säure- oder/und photolabile Schutzgruppe ist und Y eine durch Katalyse abspaltbare Schutzgruppe ist und R eine Nukleobase oder einen Fluorophor, einen Chromophor oder eine andere Markierungsgruppe darstellt. Nach Abspaltung von Y im basischen Milieu wird dann das 3'- Phosphat von der 2'-Hydroxygruppe unter Ausbildung eines zyklischen Phosphats angegriffen, was einer Hydrolyse gleichkommt und zur Wiederherstellung der ursprünglichen Hydroxygruppe führt. Bei Verwendung eines RNA-Teilabschnitts als Sonden-"Sockel" kann eine chemische Regeneration des Reaktionsträgers erfolgen. Dabei wird zunächst die Synthese unter Verwendung von 2'-OH-geschützten Phosphitamidbausteinen durchgeführt. Nach Hybridisierung wird die Schutzgruppe des RNA-Teilabschnitts abgespalten, woraus eine freie 2'- OH-Gruppe resultiert. Daraufhin kann in einem folgenden chemischen Reaktionsschritt mit Hilfe von Perjodat oder anderen Oxidationsmitteln der Ribosezucker gespalten und die Sonde durch ß-Eliminierung vom Reaktionsträger entfernt werden.wherein X and Y are protective groups orthogonal to one another, where X is, for example, an acid- and / or photolabile protective group and Y is a protective group which can be split off by catalysis and R represents a nucleobase or a fluorophore, a chromophore or another labeling group. After Y has been split off in a basic medium, the 3'-phosphate is attacked by the 2'-hydroxy group to form a cyclic phosphate, which is equivalent to hydrolysis and leads to the restoration of the original hydroxy group. If an RNA section is used as a probe "base", chemical regeneration of the reaction carrier can take place. The synthesis is first carried out using 2'-OH-protected phosphitamide building blocks. After hybridization, the protective group of the RNA section is split off, resulting in a free 2'-OH group. The ribose sugar can then be cleaved in a subsequent chemical reaction step using periodate or other oxidizing agents and the probe can be removed from the reaction carrier by β-elimination.
Die erfindungsgemäße Verbindung la lässt sich auch durch geeignete biochemische Ansätze ohne das Einkoppeln eines speziellen Moleküls zum zerstörungsfreien Recycling der Oberflächen einsetzen. Hierbei werden die mit dem Reaktionsträger verknüpften Polymer- bzw. Oligomersonden mit einem DNA- bzw. RNA-abbauenden Enzym oder einem Peptid-spaltenden Enzym gespalten, wodurch es zu einem teilweisen oder vollständigen Abbau der Sonden kommt. Im Anschluß kann der Reaktionsträger erneut zur Synthese neuer Sonden verwendet werden.The compound la according to the invention can also be used by means of suitable biochemical approaches without the coupling in of a special molecule for the non-destructive recycling of the surfaces. Here, the polymer or oligomer probes linked to the reaction carrier are cleaved with a DNA or RNA-degrading enzyme or a peptide-cleaving enzyme, which leads to partial or complete degradation of the probes. The reaction support can then be used again for the synthesis of new probes.
Als Enzyme kommen Nucleasen wie Exonucleasen oder Endonucleasen in Frage, die einen Nucleinsäurestrang von den Enden bzw. innerhalb des Sondenstrangs angreifen und Nucleotide bzw. Nucleoside als Spaltprodukte hinterlassen. Im Falle von RNA ist die Verwendung von RNAsen (wie RNAse H usw.) möglich, die bei Ausbildung eines RNA-DNA-Doppelstrangs selektiv den RNA-Teil zerschneiden, wodurch bei RNA-Sonden die gesamte Sonde und bei RNA-Teilabschnitten als Sollbruchstelle der RNA-Abschnitt gespalten wird. Die Regeneration eines Reaktionsträgers mit DNA-Sonden kann ebenfalls durch Einsatz von DNAsen (DNAse l, DNAse II, etc.) erreicht werden, wodurch sowohl einzelsträngige als auch doppelsträngige DNA abgebaut werden kann. Ebenfalls können Peptid-spaltende Enzyme für den Abbau von Peptidsonden bzw. Peptid-Sequenzabschnitten als Sollbruchstelle eingesetzt werden.Suitable enzymes are nucleases such as exonucleases or endonucleases, which attack a strand of nucleic acid from the ends or within the probe strand and leave nucleotides or nucleosides as cleavage products. In the case of RNA, the use of RNAsen (such as RNAse H etc.) is possible, which selectively cut the RNA part when an RNA-DNA double strand is formed, as a result of which the entire probe is used as the predetermined breaking point in the case of RNA probes and in the case of RNA sections RNA section is cleaved. The regeneration of a reaction carrier with DNA probes can also be achieved by using DNAse (DNAse I, DNAse II, etc.), whereby both single-stranded and double-stranded DNA can be degraded. Peptide-cleaving enzymes can also be used as a predetermined breaking point for the degradation of peptide probes or peptide sequence sections.
Ein weiterer Vorteil der erfindungsgemäßen Verbindungen besteht darin, dass auf Grund der Verzweigung eine Signalamplifikation erfolgt, da die Dotierungsdichte der funktioneilen Gruppen auf der Oberfläche erhöht wird. Weiterhin zeichnen sich die erfindungsgemäßen Verbindungen dadurch aus, dass sie eine kostengünstigere Polymersynthese ermöglichen und sich ohne weiteres in die DNA-Festphasensynthese integrieren lassen bei gleichzeitiger Verringerung der benötigten Amiditports gegenüber der Verwendung kommerziell erhältlicher Amidite.Another advantage of the compounds according to the invention is that signal amplification takes place due to the branching, since the doping density of the functional groups on the surface is increased. Furthermore, the compounds according to the invention are distinguished by the fact that they enable more cost-effective polymer synthesis and can be easily integrated into the DNA solid-phase synthesis, while at the same time reducing the required amidite ports compared to the use of commercially available amidites.
Die Herstellung der erfindungsgemäßen Verbindungen erfolgt durch U msetzung der monogeschützten Spacergrundmoleküle mit Phosphortrichlorid zum bisubstituierten Monochlorderivat. Anschließend wird dann das sekundäre Amin in das Molekül eingeführt.The compounds according to the invention are prepared by reacting the mono-protected basic spacer molecules with phosphorus trichloride to give the bisubstituted monochloro derivative. The secondary amine is then introduced into the molecule.
Weiterhin soll die Erfindung durch das nachfolgende Beispiel erläutert werden.The invention is further illustrated by the following example.
Beispiel 1 :Example 1 :
Herstellung von Bis (9-O-dimethoxytrityltriethylenglykol)-[N,N-diisopropyI]- phosphoramiditPreparation of bis (9-O-dimethoxytrityltriethylene glycol) - [N, N-diisopropyI] - phosphoramidite
1 ,37 g ( 1 0 mmol) PCI3 und 5 Äquivalente N-Ethyldiisopropylamin oder Pyridin werden unter Schutzgas in absolutem Ether aufgenommen. Zu dieser gekühlten Lösung wird monotrityliertes Triethylenglykol, gelöst in Ether und N-Ethyldiisopropylamin, langsam zugetropft. Nach zweistündigem Rühren bei Raumtemperatur werden 3 Äquivalente Diisopropylamin, gelöst in Ether, langsam zu dem Reaktionsansatz getropft. Anschließend lässt man den Ansatz weitere 1 2 h bei Raumtemperatur rühren. Nach dem Einengen wird der Ansatz in Methylenchlorid aufgenommen und mehrfach mit den üblichen Lösungen extrahiert, bevor die Substanz dann durch Chromatographie an Kieselgel isoliert wird.1.37 g (10 mmol) of PCI 3 and 5 equivalents of N-ethyldiisopropylamine or pyridine are taken up under protective gas in absolute ether. Monotritylated triethylene glycol, dissolved in ether and N-ethyldiisopropylamine, is slowly added dropwise to this cooled solution. After stirring for two hours at room temperature, 3 equivalents of diisopropylamine, dissolved in ether, are slowly added dropwise to the reaction mixture. The mixture is then left for a further 1 2 h at room temperature stir. After concentration, the mixture is taken up in methylene chloride and extracted several times with the customary solutions before the substance is then isolated by chromatography on silica gel.
Das Syntheseschema ist in Abb. 1 A dargestellt.The synthesis scheme is shown in Fig. 1A.
Beispiel 2:Example 2:
Alternativ von der in Beispiel 1 beschriebenen Vorgehensweise kann PCI3 auch mit heterocyclischen Stickstoffbasen, wie Pyrrol, Triazol oder Imidazol, umgesetzt und dann erst mit monotrityliertem Triethylenglykol gegebenenfalls in Gegenwart eines Aktivators, wie etwa Tetrazol, umgesetzt werden.As an alternative to the procedure described in Example 1, PCI 3 can also be reacted with heterocyclic nitrogen bases, such as pyrrole, triazole or imidazole, and then only with monotritylated triethylene glycol, if appropriate in the presence of an activator, such as tetrazole.
Die entsprechenden Syntheseschemata sind in Abb. 1 B und 1 C dargestellt. The corresponding synthesis schemes are shown in Fig. 1 B and 1 C.
Claims
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10041539 | 2000-08-24 | ||
| DE10041539A DE10041539A1 (en) | 2000-08-24 | 2000-08-24 | New amidite derivatives for the synthesis of polymers on surfaces |
| PCT/EP2001/009812 WO2002016375A1 (en) | 2000-08-24 | 2001-08-24 | Novel amidite derivatives for synthesising polymers on surfaces |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1311516A1 true EP1311516A1 (en) | 2003-05-21 |
Family
ID=7653615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP01969645A Withdrawn EP1311516A1 (en) | 2000-08-24 | 2001-08-24 | Novel amidite derivatives for synthesising polymers on surfaces |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040039189A1 (en) |
| EP (1) | EP1311516A1 (en) |
| AU (1) | AU2001289835A1 (en) |
| DE (1) | DE10041539A1 (en) |
| WO (1) | WO2002016375A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10041542A1 (en) * | 2000-08-24 | 2002-03-07 | Febit Ferrarius Biotech Gmbh | New strategy for the synthesis of polymers on surfaces |
| GB0129012D0 (en) | 2001-12-04 | 2002-01-23 | Solexa Ltd | Labelled nucleotides |
| JP2006509040A (en) | 2002-08-23 | 2006-03-16 | ソレックサ リミテッド | Modified nucleotides |
| US7414116B2 (en) | 2002-08-23 | 2008-08-19 | Illumina Cambridge Limited | Labelled nucleotides |
| US11008359B2 (en) | 2002-08-23 | 2021-05-18 | Illumina Cambridge Limited | Labelled nucleotides |
| BR112015022448B1 (en) | 2013-03-15 | 2020-12-08 | Illumina Cambridge Limited | modified nucleotide or nucleoside molecule, methods for preparing the growth of polynucleotide complementary to single-stranded target polynucleotide in sequencing reaction and to determine the sequence of single-stranded target polynucleotide and kit |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5637684A (en) * | 1994-02-23 | 1997-06-10 | Isis Pharmaceuticals, Inc. | Phosphoramidate and phosphorothioamidate oligomeric compounds |
| US6172217B1 (en) * | 1996-12-27 | 2001-01-09 | Isis Pharmaceuticals Inc. | Method of synthesizing phosphorothioate oligonucleotides |
| US6069243A (en) * | 1998-10-06 | 2000-05-30 | Isis Pharmaceuticals, Inc. | Process for oligonucleotide synthesis |
-
2000
- 2000-08-24 DE DE10041539A patent/DE10041539A1/en not_active Withdrawn
-
2001
- 2001-08-24 EP EP01969645A patent/EP1311516A1/en not_active Withdrawn
- 2001-08-24 US US10/362,503 patent/US20040039189A1/en not_active Abandoned
- 2001-08-24 AU AU2001289835A patent/AU2001289835A1/en not_active Abandoned
- 2001-08-24 WO PCT/EP2001/009812 patent/WO2002016375A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO0216375A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE10041539A1 (en) | 2002-03-07 |
| WO2002016375A1 (en) | 2002-02-28 |
| AU2001289835A1 (en) | 2002-03-04 |
| US20040039189A1 (en) | 2004-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0399330B1 (en) | Modified phosphoramidite process for preparing modified nucleic acids | |
| EP1801114B1 (en) | Polynucleotides with a phosphate mimetic | |
| EP0152459B1 (en) | Process for producing oligonucleotides | |
| DE69131164T2 (en) | INTRODUCTION OF SELECTIVELY FISSILE POINTS IN OLIGONUCLEOTIDE CHAINS AND REAGENTS THEREFOR | |
| DE69632456T2 (en) | NUCLEIC ACID SYNTHESIS USING MEDIUM-SHIFTABLE PROTECTION GROUPS | |
| US5367066A (en) | Oligonucleotides with selectably cleavable and/or abasic sites | |
| US5258506A (en) | Photolabile reagents for incorporation into oligonucleotide chains | |
| DE3855055T2 (en) | Chemical blocking by phosphithylation during oligonucleotide synthesis | |
| DE3855275T4 (en) | Non-nucleotide binding reagent for nucleotide samples | |
| DE69033986T2 (en) | Uncharged morpholine-based polymers with chiral, phosphorus-containing bridges between the subunits | |
| DE69725866T2 (en) | SOLID PHASE SYNTHESIS | |
| DE69125380T2 (en) | HYDROXYL PROTECTIVE GROUPS REMOVABLE BY ORTHOGONAL REDUCTION AND THEIR USE IN THE CHEMICAL SYNTHESIS OF OLIGONUCLEOTIDES | |
| DE69724218T2 (en) | UNIVERSAL FIXED CARRIERS AND METHOD FOR THEIR USE | |
| DE69116864T2 (en) | METHOD AND MEANS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES | |
| DE3785343T2 (en) | ALPHA OLIGONUCLEOTIDES. | |
| DE60209128T2 (en) | ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS | |
| DE4227882A1 (en) | FUNCTIONALIZED RAIL MATERIALS FOR SIMULTANEOUS SYNTHESIS AND DIRECT MARKING OF OLIGONUCLEOTIDES AS A PRIMER FOR MATRICES-BASED ENZYMATIC NUCLEENESEURESYNTHESES | |
| US5252760A (en) | Method of using colored phosphorylating reagents | |
| DE3650371T2 (en) | 0,0'-Dicyanoethyl-phosphoramidites, process for their preparation and their use in phosphorylation reactions. | |
| DE4213703A1 (en) | Fluorescence-labeled compounds, their production and use | |
| DE60109047T2 (en) | SYNTHONE FOR THE MANUFACTURE OF OLIGONUCLEOTIDES | |
| EP0002322A2 (en) | Improved Triester process for the synthesis of oligonucleotides | |
| EP0124561B1 (en) | Process for producing oligonucleoside phosphonates | |
| WO2002016375A1 (en) | Novel amidite derivatives for synthesising polymers on surfaces | |
| DE3881691T2 (en) | POLYDEOXYRIBONUCLEOTIDES, PHARMACEUTICAL COMPOSITIONS, USE AND PRODUCTION OF POLYDEOXYRIBONUCLEOTIDES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20030214 |
|
| AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20050301 |